CHASE INVESTMENT COUNSEL CORP
Position in LNTH — Lantheus Holdings, Inc.
CIK 19475
CHARLOTTESVILLE, VA
Position in LNTH
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$2,218,800
+$701,800 QoQ
Shares Held
20,000
0.0% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#149
of 462 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LNTH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026CHASE INVESTMENT COUNSEL CORP holds $10,003,660 across 4 Drug Manufacturers - Specialty & Generic names. LNTH ranks #2 (22.2% of the industry book) .
All Filings in LNTH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,218,800 | 20,000 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,517,000 | 20,000 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,331,000 | 20,000 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,025,800 | 20,000 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $1,637,200 | 20,000 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $1,952,000 | 20,000 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,431,360 | 16,000 | Shares | Sole | 2025-02-05 | |
| No filing history on record for this holder in this stock. | ||||||